Updating!
Coming soon!
Coming soon!
Includes all SEC registration details as well as a list of all documents (S-1, Prospectus, Current Reports, 8-K, 10K, Annual Reports) filed by Telomir Pharmaceuticals, Inc.
Filings | Format | Description | Filed/Effective | File/Film Number |
---|---|---|---|---|
8-K | Document | Current report filing Acc-no: 0001493152-24-014616 (34 Act) Size: 4112 KB |
Apr-15-2024 | 24844815 |
8-K | Document | Current report filing Acc-no: 0001493152-24-014446 (34 Act) Size: 204 KB |
Apr-12-2024 | 24841451 |
10-K | Document | Annual report pursuant to section 13 and 15(d) Acc-no: 0001493152-24-012049 (34 Act) Size: 3503 KB |
Mar-29-2024 | 24804907 |
4 | Document | Statement of changes in beneficial ownership of securities Acc-no: 0000897069-24-000395 ( Act) Size: 11 KB |
Feb-15-2024 | |
8-K | Document | Current report filing Acc-no: 0001493152-24-006094 (34 Act) Size: 968 KB |
Feb-13-2024 | 24626444 |
424B4 | Document | Prospectus filed pursuant to Rule 424(b)(4) Acc-no: 0001493152-24-005876 (33 Act) Size: 3378 KB |
Feb-12-2024 | 24619394 |
424B1 | Document | Prospectus filed pursuant to Rule 424(b)(1) Acc-no: 0001493152-24-005873 (33 Act) Size: 3454 KB |
Feb-12-2024 | 24619372 |
EFFECT | Document | Acc-no: 9999999995-24-000352 (33 Act) Size: 1 KB | Feb-08-2024 | 24610967 |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000287 ( Act) Size: 23 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000285 ( Act) Size: 10 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000283 ( Act) Size: 3 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000281 ( Act) Size: 9 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000279 ( Act) Size: 10 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000277 ( Act) Size: 9 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000275 ( Act) Size: 9 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000273 ( Act) Size: 10 KB |
Feb-08-2024 | |
3 | Document | Initial statement of beneficial ownership of securities Acc-no: 0000897069-24-000271 ( Act) Size: 10 KB |
Feb-08-2024 | |
CERT | Document | Acc-no: 0001354457-24-000052 (34 Act) Size: 174 KB | Feb-08-2024 | 24609472 |
8-A12B | Document | Form for the registration / listing of a class of securities on a national securities exchange pursuant to section 12(b) Acc-no: 0001493152-24-005143 (34 Act) Size: 26 KB |
Feb-06-2024 | 24601318 |
CORRESP | Document | A correspondence can be sent as a document with another submission type or can be sent as a separate submission. Acc-no: 0001493152-24-005026 ( Act) Size: 13 KB |
Feb-06-2024 |
Recent 20 filings. View all Telomir Pharmaceuticals, Inc. filings
young lad who new his job ansered questions and new what was best for me.
Huge help thank you for your help .. y'all make it so much easier
Very good communication and delivery made within the timeframe I was advised of
Disclaimer: The information on the Service is provided with the understanding that the Company is not herein engaged in rendering legal, accounting, tax, or other professional advice and services. As such, it should not be used as a substitute for consultation with professional accounting, tax, legal or other competent advisers.
© 2022 CompaniesBIO.Com. All rights reserved. Operated by